FOR LIVE SUPPORT, CALL 1-877-744-5675| $ REGISTER FOR A $0 CO-PAY CARD Limits, terms, and conditions apply.
FOR LIVE SUPPORT, CALL 1-877-744-5675| $ REGISTER FOR A $0 CO-PAY CARD Limits, terms, and conditions apply.
LORBRENA® (lorlatinib) is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC)
It is not known if LORBRENA is safe and effective in children.
The effectiveness of LORBRENA is based on a study that measured tumor response rate and duration of response. There is an ongoing study to find out how LORBRENA works over a longer period of time.
Help identifying resources for eligible patients without any form of healthcare coverage:
Help finding coverage
Free medicine through the Pfizer Patient Assistance Program‡, or at a savings through the Pfizer Savings Program||
‡The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™.
The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc., with distinct legal restrictions.
§The Pfizer Savings Program is not health insurance. For more information, call the toll-free number:
There are no membership fees to participate in this program. Estimated savings are 50% and depend on such factors as the particular drug purchased, amount purchased, and the pharmacy where purchased.
If these problems are severe, your healthcare provider may need to have you stop taking LORBRENA.
–Females who are able to become pregnant should use effective non-hormonal birth control during treatment with LORBRENA and for at least 6 months after the final dose of LORBRENA. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not be effective if used during treatment with LORBRENA. Talk to your healthcare provider about birth control choices that are right for you during this time.
–Males who have female partners who are able to become pregnant should use effective birth control during treatment with LORBRENA and for at least 3 months after the final dose of LORBRENA.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
Do not take LORBRENA if you take certain other medicines called strong CYP3A inducers. Ask your healthcare provider for a list of these medicines if you are not sure.
LORBRENA may cause decreased fertility in males. In males, this could affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.
These are not all of the possible side effects of LORBRENA. For more information, ask your healthcare provider or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
LORBRENA is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC)
It is not known if LORBRENA is safe and effective in children.
The effectiveness of LORBRENA is based on a study that measured tumor response rate and duration of response. There is an ongoing study to find out how LORBRENA works over a longer period of time.
Please see Full Prescribing Information and Patient Information.